NL-OMON51323RecruitingPhase 3
MR-guided LITT therapy in patients with primary irresectable glioblastoma: a multicenter randomized controlled trial - EMITT trial
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 238
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 64 (—)
Inclusion Criteria
- •- Informed consent, age >18-year-old
- •- Supratentorial localization
- •- Safe trajectory/trajectories possible for ablation of at least 70% of the
- •tumour, avoiding eloquent structures.
- •- Karnofsky Performance Status (KPS) >= 70
Exclusion Criteria
- •- Contra-indication for general anaesthesia or MRI
- •- Non-glioblastoma diagnosis on pathology analysis
- •- No final pathology diagnosis available
- •- Pregnancy
Investigators
Similar Trials
Completed
Phase 2
MR-guided LITT therapy in patients with primary irresectable glioblastoma: a randomized pilot studybrain cancer10029211glioblastomaNL-OMON55122Radboud Universitair Medisch Centrum15
Completed
Not Applicable
MR-guided LITT Therapy in Patients With Primary Irresectable GlioblastomaGlioblastomaNCT04596930Radboud University Medical Center15
Completed
Not Applicable
Optimized Magnetic Resonance Imaging in patients with tongue cancersTongue cancer and normal subjectsJPRN-UMIN000024075Tokyo Medical and Dental University40
Unknown
Not Applicable
Clinical study for Intensity Modulated RadiotherapyHepatic cancer, prostate cancer,brain, head and neck cancerJPRN-UMIN000000641Department of Radiology, Keio University5
Completed
Not Applicable
Efficacy of MRI in primary care for patients with knee complaints due to traumaKnee injuriesknee compaints10043237NL-OMON41300Erasmus MC, Universitair Medisch Centrum Rotterdam360